サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494309

アジア太平洋地域のdPCRとqPCR：2030年市場予測- 地域別分析- 治療、製品、用途、エンドユーザー別

Asia Pacific dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

出版日
ページ情報
英文 105 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アジア太平洋地域のdPCRとqPCR：2030年市場予測- 地域別分析- 治療、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 105 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域のdPCRとqPCR市場は、2022年に19億1,343万米ドルと評価され、2030年には41億3,950万米ドルに達すると予測され、2022年から2030年までのCAGRは10.1%で成長すると予測されています。

PCR技術の技術進歩がアジア太平洋地域のdPCRとqPCR市場を牽引

ポリメラーゼ連鎖反応（PCR）は、ほとんどの分子生物学ラボで、遺伝子型判定、クローニング、一塩基変異の解析のために特定のDNAストレッチを増幅するために使用される、ほぼユビキタスで堅牢かつ信頼性の高い技術であり、ほとんどの次世代シーケンサー（NGS）調製の基礎としても機能します。技術の進歩はさまざまなタイプのPCR技術を生み出しています。PCR技術の使用は現在、いくつかの非従来型用途に応用され、分子診断をより簡単かつ迅速にしています。特に、デジタルPCRやリアルタイムPCRの進歩は、病気の診断、ウイルスやバクテリアの同定、法医学的捜査の補助などに利用されています。さらに研究者たちは、いくつかのナノ材料を用いて検査時間の短縮を試みています。2023年3月、韓国科学技術院（KIST、院長：Seok Jin Yoon）の拡張知能安全システムセンター（Center for Augmented Safety System with Intelligence, Sensing）は、Dr. Sang Kyung Kim（所長）とDr. Seungwon Jungの研究チームによる超高速PCR技術の開発を発表しました。超高速PCRは、光熱ナノ材料を利用することで、検査時間を従来の10分の1に短縮しました。新しい検査法の診断性能は現行の検査法に匹敵し、5分で終了します。このように、PCR技術の技術的進歩がアジア太平洋地域のdPCRとqPCR市場の成長を促進しています。

アジア太平洋地域のdPCRとqPCR市場概要

アジア太平洋地域のdPCRとqPCR市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。中国、インド、日本は、これらの国々における外国直接投資の増加、高度に熟練した効率的で多数の労働力、バイオテクノロジー分野への高額の投資をもたらす政府政策の合理化によって、市場の成長に大きく貢献しています。さらに、感染症や慢性疾患の増加、政府や非政府の取り組みも、アジア太平洋地域のdPCRとqPCR市場の成長を後押ししています。

アジア太平洋地域のdPCRとqPCR市場の収益と2030年までの予測（金額）

アジア太平洋地域のdPCRとqPCR市場のセグメンテーション

アジア太平洋地域のdPCRとqPCR市場は、治療、製品、用途、エンドユーザー、国に基づいてセグメント化されます。

治療に基づき、アジア太平洋地域のdPCRとqPCR市場は定量PCR（qPCR）とデジタルPCR（dPCR）に二分されます。2022年にはデジタルPCR（dPCR）セグメントのシェアが大きくなった。

製品別では、アジア太平洋地域のdPCRとqPCR市場は試薬&消耗品、機器、ソフトウェア&サービスに区分されます。2022年には試薬＆消耗品セグメントが最大のシェアを占めました。

用途別では、アジア太平洋地域のdPCRとqPCR市場は、研究用途、臨床用途、法医学用途に分けられます。2022年には臨床応用分野が最大のシェアを占めました。臨床用途セグメントはさらに、腫瘍学検査、血液スクリーニング、感染症検査、その他の用途に細分化されます。

エンドユーザー別では、アジア太平洋地域のdPCRとqPCR市場は、病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、法医学研究所、臨床研究機関に区分されます。病院と診断センターセグメントが2022年に最大のシェアを占めました。

国別では、アジア太平洋地域のdPCRとqPCR市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋地域のdPCRとqPCR市場は中国が独占。

Abbott Laboratories社、Thermo Fisher Scientific Inc社、Takara Bio Inc社、Genome Diagnostics Pvt Ltd社、Qiagen NV社、Standard BioTools Inc社、Lepu Medical Technology Beijing Co Ltd社、F. Hoffmann-La Roche Ltd社、Bio-Rad Laboratories Inc社、Agilent Technologies Inc社は、アジア太平洋地域のdPCRとqPCR市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域のdPCRとqPCR市場- 主要産業力学

  • 市場促進要因
    • 遺伝病および感染症の発生率の増加
    • 遺伝子合成への投資と資金の増加
    • PCR技術の技術的進歩
  • 市場抑制要因
    • PCRシステムの高コスト
    • qPCRに伴う技術的限界
  • 市場機会
    • 新興国におけるPCR法の採用拡大
  • 今後の動向
    • 液滴デジタルPCRの発展
  • 影響分析

第5章 dPCRとqPCR市場：アジア太平洋地域市場分析

  • アジア太平洋地域のdPCRとqPCR市場収益、2022年～2030年

第6章 アジア太平洋地域のdPCRとqPCR市場-2030年までの収益と予測-治療別

  • アジア太平洋地域のdPCRとqPCR市場の収益シェア、治療別、2022年および2030年（%）
  • 定量的PCR
  • デジタルPCR

第7章 アジア太平洋地域のdPCRとqPCR市場-2030年までの収益と予測- 製品別

  • アジア太平洋地域のdPCRとqPCR市場の2022年および2030年の製品別売上高シェア（%）
  • 試薬・消耗品
  • 装置
  • ソフトウェア＆サービス

第8章 アジア太平洋地域のdPCRとqPCR市場- 用途別収益と2030年までの予測

  • アジア太平洋地域のdPCRとqPCR市場の2022年および2030年の用途別売上高シェア（%）
  • 調査用途
  • 臨床用途
  • 法医学用途

第9章 アジア太平洋地域のdPCRとqPCR市場：エンドユーザー別収益と2030年までの予測

  • アジア太平洋地域のdPCRとqPCR市場の2022年および2030年のエンドユーザー別売上高シェア（%）
  • 病院および診断センター
  • 製薬会社およびバイオテクノロジー企業
  • 調査研究所および学術機関
  • 法医学研究所
  • 臨床研究機関

第10章 アジア太平洋地域のdPCRとqPCR市場：国別分析

    • アジア太平洋地域のdPCRとqPCR市場：国別
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 dPCRとqPCR市場-業界情勢

  • アジア太平洋地域のdPCRとqPCR市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific dPCR and qPCR Market Segmentation
  • Table 2. Asia Pacific dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. India: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Australia: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Australia: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Australia: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. South Korea: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. South Korea: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. South Korea: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. South Korea: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Asia Pacific dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Asia Pacific dPCR and qPCR Market
  • Table 35. Glossary of Terms, Asia Pacific dPCR and qPCR Market

List Of Figures

  • Figure 1. Asia Pacific dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Asia Pacific dPCR and qPCR Market
目次
Product Code: BMIRE00029880

The Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030; it is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Technological Advancements in PCR Technologies Drive Asia Pacific dPCR and qPCR Market

Polymerase chain reaction (PCR) is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations and even serves as the basis for most next-generation sequencing (NGS) preparation. Technological advances are yielding different types of PCR techniques. The use of PCR technology has now been explored into several non-conventional applications, making molecular diagnosis easier and faster. In particular, advances in digital and real-time PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Moreover, the researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon) announced the development of an ultrafast PCR technology by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by ten times compared to the previous test by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to the current test method, and it can be finished in 5 minutes. Thus, technological advancements in PCR technologies propel the Asia Pacific dPCR and qPCR market growth.

Asia Pacific dPCR and qPCR Market Overview

The Asia Pacific dPCR and qPCR market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China, India and Japan are three major contributors to the growth of the market which is driven by increasing foreign direct investments in these countries, highly skilled, efficient and large number of labor, and streamlining government policies resulting in high investments for biotechnology sector. In addition, increasing cases of infectious and chronic diseases and government and non-government initiatives are also responsible for fueling the growth of the Asia Pacific dPCR and qPCR market.

Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific dPCR and qPCR Market Segmentation

The Asia Pacific dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Asia Pacific dPCR and qPCR market is research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Genome Diagnostics Pvt Ltd, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Asia Pacific dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 Asia Pacific dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific dPCR and qPCR Market - Country Analysis

    • 10.1.1 Asia Pacific dPCR and qPCR Market, by Country
      • 10.1.1.1 China
        • 10.1.1.1.1 China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 China: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 China: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 China: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 China: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Japan
        • 10.1.1.2.1 Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Japan: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Japan: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Japan: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Japan: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 India
        • 10.1.1.3.1 India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 India: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 India: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 India: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 India: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.4 Australia
        • 10.1.1.4.1 Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Australia: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Australia: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Australia: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.4.1 Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.4.5 Australia: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.5 South Korea
        • 10.1.1.5.1 South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 South Korea: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.5.4 South Korea: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.5.4.1 South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.5.5 South Korea: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific
        • 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Asia Pacific dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Genome Diagnostics Pvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms